Granulocyte colony-stimulating factor (G-CSF) dose-dependent efficacy in peripheral blood stem cell mobilization in patients who had failed initial mobilization with chemotherapy and G-CSF.

Autor: Lie, A K W, Hui, C H, Rawling, T, Dyson, P G, Thorp, D, Benic, J, Rawling, C M, Toogood, I, Horvath, N, Simmons, P J, To, L B
Předmět:
Zdroj: Bone Marrow Transplantation; 11/1/98, Vol. 22 Issue 9, p853, 5p
Abstrakt: For 10 consecutive patients in our unit who did not show a significant rise in blood progenitor cells within 14 days following chemotherapy and G-CSF, we increased the G-CSF dose from 5 to 10 μg/kg/day (n = 9) or from 10 to 15 μg/kg/day (n = 1). As a result, there were significant increases in total yield as well as yield per apheresis of mononuclear cells, CD34+ cells and CFU-GM (P < 0.025, <0.01 and <0.005, respectively). after g-csf dose escalation, six of the 10 patients had sufficient cd34+ cells for performing transplantation. These results demonstrate a dose-dependent response of progenitor cell mobilization by G-CSF when used in combination with chemotherapy. Moreover, increasing the dose of G-CSF as late as the third week of mobilization may still provide sufficient cell yield even with patients who did not show a significant mobilization with conventional doses of G-CSF. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index